Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer...http://www.google.es/patents/US7771742?utm_source=gb-gplus-sharePatente US7771742 - Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods